社区获得性肺炎的中西医治疗研究进展

社区获得性肺炎(Community Acquired Pneumonia,CAP)是比较常见的院外肺部炎性疾病之一,随着细菌、支原体、衣原体等多种病原体的耐药率的上升,以及病患梯度的范围增加,CAP的发病率呈逐年上升的趋势,死亡率日益增高,导致医疗资源消耗巨大。目前临床上CAP的患者主要依靠经验性治疗。正确选择抗生素、减少病原体的耐药率,优化肺部炎症疾病的医疗方案,提高CAP临床治愈率已经成为临床医生当前面临的一项重大挑战。中药制剂具有广谱抗菌、调节免疫、不易耐药、简便价廉等特点,是解决上述难题的一个很好途径。

Progress in Research of Community Acquired Pneumonia in Traditional Chinese and Western Medicine

Community acquired pneumonia is one of the most common pulmonary inflammatory diseases outside the hospital.With the increase of drug resistance rate of bacteria,mycoplasma,chlamydia and other pathogens,as well as the increase of patient gradient,the incidence of CAP is increasing year by year,and the death rate is increasing,which leads to huge consumption of medical resources.Now clinically,CAP patients mainly rely on empirical treatment.It has become a major challenge for clinicians to select antibiotics correctly,reduce the resistance rate of pathogens,optimize the medical scheme of pulmonary inflammatory diseases,and improve the clinical cure rate of CAP.Traditional Chinese medicine preparation has the characteristics of broad-spectrum antibacterial,immune regulation,not easy to drug resistance,simple and cheap,which is a good way to solve the above problems.This paper aims to analyze the general situation of community acquired pneumonia in the past 15 years at home and abroad.